Acuta Capital Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-27,500
| Closed | -$1.3M | – | 49 |
|
|
2022
Q2 | $1.3M | Buy |
27,500
+25,200
| +1,096% | +$1.19M | 0.72% | 32 |
|
|
2022
Q1 | $164K | Buy |
+2,300
| New | +$164K | 0.08% | 37 |
|
|
2019
Q2 | – | Sell |
-61,000
| Closed | -$5.83M | – | 32 |
|
|
2019
Q1 | $5.83M | Buy |
+61,000
| New | +$5.83M | 2.77% | 14 |
|
|
2015
Q1 | – | Sell |
-44,528
| Closed | -$2.26M | – | 51 |
|
|
2014
Q4 | $2.26M | Buy |
+44,528
| New | +$2.26M | 1.53% | 15 |
|